Truth that Matters. Stories that Impact

Truth that Matters. Stories that Impact

Technology

AI Startup Simile Raises $200 Million Series B at $2 Billion Valuation

Artificial intelligence startup Simile has achieved a $2 billion valuation after securing $200 million in a Series B funding round. The funding announcement comes five months after the company emerged from stealth with a $100 million Series A round.

What Happened

Simile closed a $200 million Series B investment led by Greenoaks. The financing round values the startup at $2 billion. Additional investors in the round include Index Ventures, Hanabi, Bain Capital Ventures, A*, Factory, Definition, and CVS Health Ventures. CVS Health Ventures is the investment arm of CVS, which is also recognized as one of Simile’s key enterprise customers.

Key Highlights

  • Simile finalized a $200 million Series B funding round at a $2 billion valuation.
  • The round was led by Greenoaks, with participation from multiple venture firms and customer CVS Health Ventures.
  • The capital raise follows a $100 million Series A round led by Index Ventures five months prior.
  • Simile produces AI-generated synthetic users designed for marketing and product research applications.
  • The company was founded by Joon Sung Park, a Stanford PhD graduate behind the ‘Smallville’ AI simulation project.

Why This Matters

Simile operates in the emerging field of synthetic user simulation, developing AI tools that aim to assist companies with product mock-ups and market analysis. The company was founded by Stanford PhD graduate Joon Sung Park, whose doctoral research included ‘Smallville,’ a project where AI agents simulated daily human lives and social interactions. Investor interest in simulated user research has grown across the sector, with related companies such as startup Aaru previously raising a Series A round in December at a $1 billion valuation.

What to Watch Next

Future developments will depend on how organizations incorporate simulated user tools into their existing market research and product development workflows.

Frequently Asked Questions

What service does Simile offer?

Simile provides simulated AI users to help organizations perform product research and marketing analysis.

Who funded Simile’s Series B round?

The $200 million round was led by Greenoaks, alongside Index, Hanabi, Bain Capital Ventures, A*, Factory, Definition, and CVS Health Ventures.

Who is the founder of Simile?

Simile was founded by Stanford PhD graduate Joon Sung Park, known for creating the ‘Smallville’ AI research project.

Source: TechCrunch